MedPath

Neptunus Pharmaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Polydatin Injectable (HW6) for Shock Treatment

Phase 2
Conditions
Shock, Hemorrhagic
Shock, Traumatic
Shock, Septic
Interventions
First Posted Date
2013-01-30
Last Posted Date
2013-01-30
Lead Sponsor
Neptunus Pharmaceuticals Inc.
Target Recruit Count
240
Registration Number
NCT01780129
Locations
🇺🇸

Christiana Care, Newark, Delaware, United States

© Copyright 2025. All Rights Reserved by MedPath